Reeve Amy K, Grady John P, Cosgrave Eve M, Bennison Emma, Chen Chun, Hepplewhite Philippa D, Morris Christopher M
1MRC/BBSRC Centre for Ageing and Vitality and Wellcome Centre for Mitochondrial Research, Institute for Neuroscience, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, NE2 4HH UK.
2Kinghorn Centre for Clinical Genomics, Garvan Institute, 384 Victoria Street, Darlinghurst, Sydney NSW 2010 Australia.
NPJ Parkinsons Dis. 2018 Mar 26;4:9. doi: 10.1038/s41531-018-0044-6. eCollection 2018.
Mitochondrial dysfunction within the cell bodies of substantia nigra neurons is prominent in both ageing and Parkinson's disease. The loss of dopaminergic substantia nigra neurons in Parkinson's disease is associated with loss of synapses within the striatum, and this may precede neuronal loss. We investigated whether mitochondrial changes previously reported within substantia nigra neurons were also seen within the synapses and axons of these neurons. Using high resolution quantitative fluorescence immunohistochemistry we determined mitochondrial density within remaining dopaminergic axons and synapses, and quantified deficiencies of mitochondrial Complex I and Complex IV in these compartments. In Parkinson's disease mitochondrial populations were increased within axons and the mitochondria expressed higher levels of key electron transport chain proteins compared to controls. Furthermore we observed synapses which were devoid of mitochondrial proteins in all groups, with a significant reduction in the number of these 'empty' synapses in Parkinson's disease. This suggests that neurons may attempt to maintain mitochondrial populations within remaining axons and synapses in Parkinson's disease to facilitate continued neural transmission in the presence of neurodegeneration, potentially increasing oxidative damage. This compensatory event may represent a novel target for future restorative therapies in Parkinson's disease.
黑质神经元胞体内的线粒体功能障碍在衰老和帕金森病中均很突出。帕金森病中多巴胺能黑质神经元的丧失与纹状体内突触的丧失有关,且这可能先于神经元丧失。我们研究了先前报道的黑质神经元内的线粒体变化是否也见于这些神经元的突触和轴突内。使用高分辨率定量荧光免疫组织化学方法,我们测定了剩余多巴胺能轴突和突触内的线粒体密度,并对这些区域中线粒体复合物I和复合物IV的缺陷进行了量化。在帕金森病中,轴突内的线粒体数量增加,且与对照组相比,线粒体表达更高水平的关键电子传递链蛋白。此外,我们在所有组中均观察到不含线粒体蛋白的突触,而在帕金森病中这些“空”突触的数量显著减少。这表明在帕金森病中,神经元可能试图维持剩余轴突和突触内的线粒体数量,以便在神经退行性变的情况下促进神经传递的持续进行,这可能会增加氧化损伤。这种代偿性事件可能代表了未来帕金森病恢复性治疗的一个新靶点。